Cargando…
Phase I non-randomized clinical trial of allogeneic natural killer cells infusion in acute myeloid leukemia patients
INTRODUCTION: A new type of immune cell transplantation called allogeneic NK cell infusion is proposed as a potential universal off-the-shelf cell product for adoptive immune cell therapy in hematologic malignancies. DESIGN: A multicentral phase I non-randomized clinical trial was conducted to asses...
Autores principales: | Ahmadvand, Mohammad, Barough, Mahdieh Shokrollahi, Barkhordar, Maryam, Faridfar, Ali, Ghaderi, Afshin, Jalaeikhoo, Hasan, Rajaienejad, Mohsen, Majidzadeh, Keivan, Ghavamzadeh, Ardeshir, Sarrami-Forooshani, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636850/ https://www.ncbi.nlm.nih.gov/pubmed/37950209 http://dx.doi.org/10.1186/s12885-023-11610-x |
Ejemplares similares
-
Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
por: Ahmadvand, Mohammad, et al.
Publicado: (2023) -
The State of Peripheral Blood Natural Killer Cells and Cytotoxicity
in Women with Recurrent Pregnancy Loss and Unexplained
Infertility
por: Azargoon, Azam, et al.
Publicado: (2019) -
Bioactivity of Exosomes Derived from Trained Natural Killer Cells versus Non-Trained One: More Functional and Antitumor Activity
por: Mohammadi, Fateme, et al.
Publicado: (2022) -
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment
por: Aghayan, Hamid Reza, et al.
Publicado: (2022) -
The Prevalence of Antifungal Agents Administration in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study
por: Kargar, Mona, et al.
Publicado: (2013)